Grants for Public housing authorities - Health

This funding opportunity provides financial support for diverse doctoral students conducting research on aging and related health issues, helping to cultivate a more inclusive scientific workforce.

This funding opportunity supports researchers exploring innovative strategies to achieve long-lasting HIV remission at the start of antiretroviral therapy, focusing on basic and preclinical studies rather than clinical trials.

This funding opportunity announcement (FOA) invites research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing. Both animal and human subjects research projects are welcome. Researchers proposing basic science experimental studies involving human participants should consider the companion FOA TEMP-14931 "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)".

This funding opportunity supports institutions in training clinical scientists focused on cancer research, enabling them to lead or participate in clinical trials as part of their career development.

(Reissue PAR-21-058). The purpose of this Program Announcement (PAR) is to enable clinical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal of this PAR is to enable the rigorous validation of biomarker measurements within the clinical population of interest to establish the positive and negative predictive values of the candidate biomarker consistent with FDA guidelines. This PAR assumes that 1) a candidate biomarker has already been identified, 2) detection method technology has already been developed and analytically validated, and 3) the research and/or clinical need and potential context of use has been identified.

This funding opportunity provides financial support to public agencies and nonprofit organizations to deliver essential primary health care services to underserved communities across the United States.

This funding opportunity supports community-led research initiatives aimed at developing and evaluating prevention strategies for intimate partner violence and sexual violence in high-risk communities, particularly among marginalized groups.

This funding opportunity provides financial support to state and local governments, educational institutions, nonprofits, and other organizations to implement strategies that promote better nutrition and physical activity, ultimately reducing chronic disease risks in their communities.

This grant provides funding for researchers studying the development of brain circuits and their relationship to behavior in rodents and non-human primates, focusing on how these processes influence mental health across different life stages.

This funding opportunity supports institutions in developing training programs for predoctoral and postdoctoral researchers focused on advancing knowledge and skills in aging research, aiming to prepare a diverse group of scientists for careers in this critical field.

This grant provides funding to support the Tanzanian government's efforts to strengthen public health systems, improve disease detection and response, and enhance laboratory capabilities to better manage health threats.

This funding opportunity supports U.S. institutions in developing educational programs that provide undergraduate and early-stage graduate students with hands-on research experiences in kidney technology development and entrepreneurship.

This funding opportunity provides financial support for organizations to deliver specialized services to victims of crime, ensuring their unique needs are met across diverse communities.

The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. This Funding Opportunity Announcement (FOA) is soliciting Transformative Research Award applications to support individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research that has the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies related to Down syndrome. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the nations research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. Applications are welcome in all topics relevant to Down syndrome-related research or its co-occurring conditions. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact in research related to Down syndrome.

This grant provides funding for researchers to investigate the harmful effects and underlying mechanisms of acute exposure to ultra-potent synthetic opioids, aiming to develop effective treatments and countermeasures for public health emergencies.

This funding opportunity provides financial support for the early development of innovative drugs aimed at preventing, slowing, or treating Alzheimer's disease and its symptoms.

This funding opportunity supports research projects that aim to improve access and effectiveness of treatment for Alcohol Use Disorder, particularly for underrepresented populations such as racial and ethnic minorities, rural communities, and LGBTQ+ groups.

The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Although all of the participating NIH Institutes and Centers (ICs) use this support mechanism to support career development experiences that lead to research independence, some ICs use the K01 award for individuals who propose to train in a new field or for individuals who have had a hiatus in their research career because of illness or pressing family circumstances. Other ICs offer separate K01 FOAs intended to increase research workforce diversity.

NHGRI aims to setup a research Consortium, ML/AI Tools to Advance Genomic Translational Research (MAGen), to collaboratively explore the feasibility of developing Machine Learning (ML) and Artificial Intelligence (AI) tools that can enhance the accuracy and precision of predicting how individuals with pathogenic genetic variants manifest disease. The primary goal is to identify both genomic and non-genomic factors influencing disease development in individuals carrying pathogenic genetic variants. The ML/AI tools will leverage existing multimodal genomic and non-genomic data and will be cross validated in genomic translational research settings to ensure the accuracy and generalizability of the tools for translational purposes. In addition, the Consortium will explore the ethical, legal, and social implications (ELSI) of integrating ML/AI tools into genomic medicine through the establishment of an ELSI Framework for their development, and through implementation of ELSI research projects.

This funding opportunity supports innovative clinical trials aimed at developing advanced imaging technologies to visualize the inner ear's structures and functions in living patients with high precision.